Pain in malignant hematology

Expert Review of Hematology

Volumn 4, Issue 1, 2011, Pages 81-93

  Niscola, Pasquale ^a   Tendas, Andrea ^a   Scaramucci, Laura ^a   Giovaninni, Marco ^a   Cupelli, Luca ^a   De Sanctis, Vitaliana ^b   Brunetti, Gregorio Antonio ^b   Bondanini, Francesco ^c   Palumbo, Roberto ^a   Lamanda, Michela ^d   Battistini, Roberta ^d   Cartoni, Claudio ^b   Romani, Claudio ^e   Arcuri, Edoardo ^f  

^a S EUGENIO HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SANDRO PERTINI HOSPITAL   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^e Ospedale Oncologico A Businco   (Italy)

^f Hospice and Palliative Care Center Sacro Cuore   (Italy)

Author keywords

bone; hematological malignancies; hematology; leukemia; lymphoma; multiple myeloma; osteolysis; pain; splenomegaly

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ASPARAGINASE; BISPHOSPHONIC ACID DERIVATIVE; BORTEZOMIB; BUSULFAN; CARMUSTINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; GLUTAMIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; IFOSFAMIDE; MELPHALAN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PALIFERMIN; PARACETAMOL; PLATINUM; TACROLIMUS; THALIDOMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VINCA ALKALOID; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANALGESIA; BONE PAIN; CANCER PAIN; CLINICAL FEATURE; CONSTIPATION; CRYOTHERAPY; CYSTALGIA; DIAGNOSTIC ACCURACY; HEMATOLOGIC MALIGNANCY; HUMAN; INSTESTINAL NEUROPATHY; JAW OSTEONECROSIS; LYMPHOMA; MEDICAL LITERATURE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NEUROPATHIC PAIN; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; NONHUMAN; ORAL MUCOSITIS; PAIN; PAIN ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SPINAL CORD COMPRESSION; THROMBOCYTOPENIA; VISCERAL PAIN; WORLD HEALTH ORGANIZATION;

ANALGESICS; HEMATOLOGIC NEOPLASMS; HUMANS; PAIN; PAIN MEASUREMENT;

EID: 79951800907     PISSN: 17474086     EISSN: None     Source Type: Journal    
DOI: 10.1586/ehm.10.79     Document Type: Review

References (90)

1. Stalfelt AM, Brodin H, Pettersson S, Eklof A. The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain. Leuk. Res. 27, 481-488 (2003). (Pubitemid 36315778)
2. Johnsen AT, Tholstrup D, Petersen MA, Pedersen L, Groenvold M. Health related quality of life in a nationally representative sample of haematological patients. Eur. J. Haematol. 83(2), 139-148 (2009).
3. Cartoni C, Efficace F, Tendas A, et al. Assessing symptoms in hematology from the patients perspective: feasibility of a patient reported instrument in clinical research. Haematologica 95(Suppl. 2), 188 (2010) (Abstract 0463).
4. Van Cleve L, Bossert E, Beecroft P, Adlard K, Alvarez O, Savedra MC. The pain experience of children with leukemia during the first year after diagnosis. Nurs. Res. 53(1), 1-10 (2004). (Pubitemid 40268492)
5. Morselli M, Bandieri E, Zanin R, et al. Pain and emotional distress in leukemia patients at diagnosis. Leuk. Res. 34(2), e67-e68 (2010).
6. Niscola P, Cartoni C, Romani C, et al. Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey. Ann. Hematol. 86(9), 671-676 (2007). (Pubitemid 47193597)
7. Niscola P, Romani C, Cartoni C, et al. Epidemiology of pain in hospital haematological setting: an Italian survey. Leuk. Res. 32(1), 197-198 (2008). (Pubitemid 350100837)
8. Niscola P. Effective pain management in hematological malignancies. Expert Rev. Hematol. 2(3), 219-222 (2009).
9. Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann. Oncol. 19(12), 1985-1991 (2008).
10. Apolone G, Corli O, Caraceni A, et al. Cancer Pain Outcome Research Study Group (CPORSG) Investigators. Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br. J. Cancer 100(10), 1566-1574 (2009).
11. Woolf CJ. American College of Physicians; American Physiological Society. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann. Intern. Med. 140(6), 441-451 (2004). (Pubitemid 38327332)
12. Fine PG, Miaskowski C, Paice JA. Meeting the challenges in cancer pain management. J. Support Oncol. 2(6 Suppl. 4), 5-22 (2004). (Pubitemid 40100648)
13. Niscola P, Arcuri E, Giovannini M, et al. Pain syndromes in haematological malignancies: an overview. Hematol. J. 5(4), 293-303 (2004). (Pubitemid 39214206)
14. Sabino MA, Mantyh PW. Pathophysiology of bone cancer pain. J. Support Oncol. 3(1), 15-24 (2005). (Pubitemid 41029576)
15. Lossignol DA, Dumitrescu C. Breakthrough pain: progress in management. Curr. Opin. Oncol. 22(4), 302-306 (2010).
16. Davis MP, Walsh D. Cancer pain: how to measure the fifth vital sign. Cleve. Clin. J. Med. 71(8), 625-632 (2004). (Pubitemid 39193337)
17. Chauhan A, Weiss J, Warrier R. Effective management of pain in pediatric hematology and oncology. Asian Pac. J. Cancer Prev. 11(2), 577-579 (2010).
18. Bennet MI. Diagnosing neuropathic pain in clinical practice. In: Neuropathic Pain. Oxford University Press, Oxford, UK, 25-35 (2006).
19. Niscola P, Scaramucci L, Romani C, et al. Pain management in multiple myeloma. Expert Rev. Anticancer Ther. 10(3), 415-425 (2010).
20. Roodman GD. Pathogenesis of myeloma bone disease. Leukemia 23(3), 435-441 (2009).
21. Takasaki H, Kanamori H, Takabayashi M, et al. Non-Hodgkins lymphoma presenting as multiple bone lesions and hypercalcemia. Am. J. Hematol. 81(6), 439-442 (2006). (Pubitemid 43787932)
22. Quintini G, Barbera V, Franco V. Bone remodeling in acute myeloid leukemia. Haematologica 86, 1006 (2001). (Pubitemid 32937719)
23. Sinigaglia R, Gigante C, Bisinella G, Varotto S, Zanesco L, Turra S. Musculoskeletal manifestations in pediatric acute leukemia. J. Pediatr. Orthop. 28(1), 20-28 (2008). (Pubitemid 351628187)
24. Jayanthan A, Miettunen PM, Incoronato A, et al. Childhood acute lymphoblastic leukemia (ALL) presenting with severe osteolysis: a model to study leukemia-βone interactions and potential targeted therapeutics. Pediatr. Hematol. Oncol. 27(3), 212-227 (2010).
25. Silberman J, Lonial S. Review of peripheral neuropathy in plasma cell disorders. Hematol. Oncol. 26(2), 55-65 (2008). (Pubitemid 351951333)
26. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. 17(9), 1113-e88 (2010).
27. Davda R, Davies S, Kumaran T. Splenic irradiation in the management of Waldenstrom macroglobulinemia. Leuk. Lymphoma 50(6), 1047-1049 (2009).
28. Mishchenko E, Tefferi A. Treatment options for hydroxyurea-refractory disease complications in myeloproliferative neoplasms: JAK2 inhibitors, radiotherapy, splenectomy and transjugular intrahepatic portosystemic shunt. Eur. J. Haematol. 85(3), 192-199 (2010).
29. Coutaux A, Salomon L, Rosenheim M, et al. Care related pain in hospitalized patients: a cross-sectional study. Eur. J. Pain 12(1), 3-8 (2008). (Pubitemid 350046371)
30. Pinto L, Liu Z, Doan Q, Bernal M, Dubois R, Lyman G. Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials. Curr. Med. Res. Opin. 23(9), 2283-2295 (2007). (Pubitemid 350246613)
31. Frieze DA. Musculoskeletal pain associated with corticosteroid therapy in cancer. Curr. Pain Headache Rep. 14(4), 256-260 (2010).
32. Baker KS, Ness KK, Weisdorf D, et al. Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Leukemia 24(12), 2039-2047 (2010).
33. Aricò M, Boccalatte MF, Silvestri D, et al. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 88(7), 747-753 (2003). (Pubitemid 36890108)
34. Srinivasan D, Shetty S, Ashworth D, Grew N, Millar B. Orofacial pain-α presenting symptom of bisphosphonate associated osteonecrosis of the jaws. Br. Dent. J. 203(2), 91-92 (2007).
35. Vahtsevanos K, Kyrgidis A, Verrou E, et al. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J. Clin. Oncol. 27(32), 5356-5362 (2009).
36. Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol. 44(9), 857-869 (2008).
37. Niscola P, Romani C, Scaramucci L, et al. Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies. Bone Marrow Transplant. 41(9), 757-764 (2008). (Pubitemid 351696338)
38. Niscola P. Mucositis in malignant hematology. Expert Rev. Hematol. 3 (1), 57-65 (2010).
39. Flores-Caldern J, Exiga-Gonzaléz E, Morán-Villota S, Martín-Trejo J, Yamamoto-Nagano A. Acute pancreatitis in children with acute lymphoblasticleukemia treated with l-asparaginase. J. Pediatr. Hematol. Oncol. 31(10), 790-793 (2009).
40. Diezi M, Nydegger A, Di Paolo ER, Kuchler H, Beck-Popovic M. Vincristine and intestinal pseudo-obstruction in children: report of 5 cases, literature review, and suggested management. J. Pediatr. Hematol. Oncol. 32(4), e126-e130 (2010).
41. Chaudhry V, Cornblath DR, Polydefkis M, Ferguson A, Borrello I. Characteristics of bortezomiβ-and thalidomide-induced peripheral neuropathy. J. Peripher. Nerv. Syst. 13(4), 275-282 (2008).
42. Mohty B, El-Cheikh J, Yakouß-Agha I, Moreau P, Harousseau JL, Mohty M. Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations. Haematologica 95(2), 311-319 (2010).
43. Cavaletti G, Jakubowiak AJ. Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies. Leuk. Lymphoma 51(7), 1178-1187 (2010).
44. Sioka C, Kyritsis AP. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother. Pharmacol. 63(5), 761-767 (2009).
45. Fujii N, Ikeda K, Koyama M, et al. Calcineurin inhibitor-induced irreversible neuropathic pain after allogeneic hematopoietic stem cell transplantation. Int. J. Hematol. 83(5), 459-461 (2006). (Pubitemid 44756801)
46. Jonsson OG, Sartain P, Ducore JM, Buchanan GR. Bone pain as an initial symptom of childhood acute lymphoblastic leukemia: association with nearly normal hematologic indexes. J. Pediatr. 117, 233-237 (1990). (Pubitemid 20238535)
47. Bauduer F, Capdupuy C, Renoux M. Characteristics of deaths in a department of oncohaematology within a general hospital. A study of 81 cases. Support Care Cancer 8(4), 302-306 (2000). (Pubitemid 30430053)
48. Hongo T, Watanabe C, Okada S, et al. Analysis of the circumstances at the end of life in children with cancer: symptoms, suffering and acceptance. Pediatr. Int. 45, 60-64 (2003). (Pubitemid 36523561)
49. Costantini M, Ripamonti C, Beccaro M, et al. Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients life. Results of an Italian mortality follow-βack survey. Ann. Oncol. 20(4), 729-735 (2009).
50. Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the MD Anderson Symptom Inventory. Cancer 89(7), 1634-1646 (2000).
51. Geeta MG, Geetha P, Ajithkumar VT, Krishnakumar P, Kumar KS, Mathews L. Management of pain in leukemic children using the WHO analgesic ladder. Indian J. Pediatr. 77(6), 665-668 (2010).
52. Kyle RA. Multiple myeloma: review of 869 cases. Mayo Clin. Proc. 50(1), 29-40 (1975).
53. Zappasodi P, Corso A, Klersy C, et al. Changes in multiple myeloma epidemiology in the last thirty years: a single centre experience. Eur. J. Cancer 42(3), 396-402 (2006). (Pubitemid 43132896)
54. Lennert H. Pain therapy in multiple myeloma-clinical experience from an observational study. The Pain Clinic 18(2)6, 131-136 (2006).
55. Lidén Y, Landgren O, Arnér S, Sjölund KF, Johansson E. Procedure-related pain among adult patients with hematologic malignancies. Acta Anaesthesiol. Scand. 53(3), 354-363 (2009).
56. Högler W, Wehl G, van Staa T, Meister B, Klein-Franke A, Kropshofer G. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database. Pediatr. Blood Cancer 48(1), 21-27 (2007). (Pubitemid 44871588)
57. Sonis ST, Elting LS, Keefe D, et al., Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl.), 1995-2025 (2004). (Pubitemid 38528741)
58. Kyle RA, Yee GC, Somerfield MR, et al. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J. Clin. Oncol. 25(17), 2464-2472 (2007). (Pubitemid 46999218)
59. Meneses CF, de Freitas JC, Castro CG Jr, Copetti F, Brunetto AL. Safety of general anesthesia for lumbar puncture and bone marrow aspirate/biopsy in pediatric oncology patients. J. Pediatr. Hematol. Oncol. 31(7), 465-470 (2009).
60. Keefe DM, Schubert MM, Elting LS, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109(5), 820-831 (2007). (Pubitemid 46335677)
61. Lilleby K, Garcia P, Gooley T, et al. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 37(11), 1031-1035 (2006).
62. Mokhtar GM, Shaaban SY, Elbarbary NS, Fayed WA. A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study. J. Pediatr. Hematol. Oncol. 2(8), 594-600 (2010).
63. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur. J. Cancer 44(11), 1507-1515 (2008).
64. Brogan S, Junkins S. Interventional therapies for the management of cancer pain. J. Support Oncol. 8(2), 52-59 (2010).
65. Raphael J, Hester J, Ahmedzai S, et al. Cancer pain: part 2: physical, interventional and complimentary therapies; management in the community; acute, treatment-related and complex cancer pain: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med. 11(6), 872-896 (2010).
66. Raphael J, Ahmedzai S, Hester J, et al. Cancer pain: part 1: pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med. 11(5), 742-764 (2010).
67. Niscola P, Scaramucci L, Romani C, et al. Opioids in pain management of blood-related malignancies. Ann. Hematol. 85(8), 489-501 (2006). (Pubitemid 44283092)
68. Chakraborty A, Wells R, Doherty M, Huynh C, Selby D. Joint pain in AML: successful pain control with radiotherapy. J. Pain Symptom Manage. 35(6), 670-672 (2008).
69. Weinmann M, Becker G, Einsele H, Bamberg M. Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders. Radiother. Oncol. 58, 235-246 (2001). (Pubitemid 32181856)
70. McFarland JT, Kuzma C, Millard FE, Johnstone PA. Palliative irradiation of the spleen. Am. J. Clin. Oncol. 26, 178-183 (2003). (Pubitemid 36443563)
71. Haas RLM, Poortmans P, de Jong D. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J. Clin. Oncol. 13, 2474-2480 (2003). (Pubitemid 46606327)
72. Garland P, Gishen P, Rahemtulla A. Percutaneous vertebroplasty to treat painful myelomatous vertebral deposits-long-term efficacy outcomes. Ann. Hematol. 90(1), 95-100 (2010).
73. Murtagh F, Edmonds P, Farnham C. Opioids in special circumstances. In: Opioids in Cancer Pain, Forbes K (Ed). Oxford University Press, Oxford, UK, 131-143 (2007).
74. Smith H, Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs Aging 27(5), 417-433 (2010).
75. Niscola P, Scaramucci L, Vischini G, et al. The use of major analgesics in patients with renal dysfunction. Curr. Drug Targets 11(6), 752-758 (2010).
76. Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin. Proc. 85(5), 451-458 (2010).
77. World Health Organization. Cancer Pain Relief. World Health Organization, Geneva, Switzerland (1986).
78. Swarm R, Anghelescu DL, Benedetti C, et al. National comprehensive cancer network (NCCN). Adult cancer pain. J. Natl Compr. Canc. Netw. 5(8), 726-751 (2007).
79. Rattray B, Nugent DJ, Young G. Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia. Haemophilia 12(5), 514-517 (2006). (Pubitemid 44227595)
80. Pergolizzi J, Böger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 8(4), 287-313 (2008).
81. Smith HS. Opioid metabolism. Mayo Clin. Proc. 84(7), 613-624 (2009).
82. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin. Pharmacokinet. 43(13), 879-923 (2004). (Pubitemid 39447033)
83. Niscola P, Perrotti AP, del Poeta G, et al. Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures. Herpes 14(2), 45-47 (2007). (Pubitemid 47556310)
84. Pergolizzi J, Aloisi AM, Dahan AA, et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract. 10(5), 428-450 (2010).
85. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-βased report. J. Clin. Oncol. 19(9), 2542-2554 (2001). (Pubitemid 32391226)
86. Pigni A, Brunelli C, Gibbins J, et al. Content development for European guidelines on the use of opioids for cancer pain: a systematic review and Expert Consensus Study. Minerva Anestesiol. 76(10), 833-843 (2010).
87. Foley KM. The treatment of cancer pain. N. Engl. J. Med. 313(2), 84-95 (1985). (Pubitemid 15068702)
88. Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology 112(1), 226-238 (2010).
89. Stanos SP, McLean J, Rader L. Physical medicine rehabilitation approach to pain. Med. Clin. North Am. 91(1), 57-95 (2007). (Pubitemid 44880057)
90. Fadul NA, El Osta B, Dalal S, Poulter VA, Bruera E. Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J. Palliat. Med. 11(3), 422-427 (2008). (Pubitemid 351440550)